Correction to "New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance".
Journal
ACS central science
ISSN: 2374-7943
Titre abrégé: ACS Cent Sci
Pays: United States
ID NLM: 101660035
Informations de publication
Date de publication:
23 Aug 2023
23 Aug 2023
Historique:
received:
24
07
2023
medline:
28
8
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
epublish
Résumé
[This corrects the article DOI: 10.1021/acscentsci.3c00286.].
Identifiants
pubmed: 37637725
doi: 10.1021/acscentsci.3c00920
pmc: PMC10450869
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
1705Commentaires et corrections
Type : ErratumFor
Informations de copyright
© 2023 The Authors. Published by American Chemical Society.